A 65-year-old former smoker with known COPD (FEV1 55% predicted) presents for routine review. He uses a long-acting muscarinic antagonist inhaler daily and salbutamol as needed. He has had two moderate exacerbations requiring oral corticosteroids and antibiotics in the past 12 months. What is the most appropriate next step in pharmacological management?